FTM Annual Symposium - 5th October 2017 - Royal College of Physicians and Surgeons of Glasgow- reduced rate for BGTHA members. Book now https://rcpsg.ac.uk/events/travelsymp
The Public Health England (PHR) report on malaria imported into the UK in 2016 is now available. Please view it here.
In 2010 a case of locally acquired chikungunya virus infection was reported in the Var department of the Provence-Alpes-Cote d’Azur region of southern France. In 2014 a case was reported in Montpellier in the Herault region. In August 2017 a third case has been reported, again in the Var department. Travellers should be aware of the possibility of chikungunya infection in southern France and should take precautions against bites from daytime biting Aedes mosquitoes. Travel health advisers should be aware of the possibility of chikungunya infection in travellers returning from southern France with symptoms typical of chikungunya such as fever, headache, myalgia arthralgia and rash.
HEPATITIS B VACCINE SHORTAGE: IMPLICATIONS AND ADVICE FOR CLINICAL PRACTICE
Public Health England publishes hepatitis B vaccine recommendations and dose sparing advice for pre and post exposure immunisation and boosting
Currently, hepatitis B vaccine is in short supply in the United Kingdom (UK); until normal vaccine supply resumes, health professionals should consider alternative vaccines, prioritisation and dose sparing.
Public Health England provides additional advice for healthcare workers providing information on hepatitis B vaccination for adults and children who travel abroad:
Public Health England. Hepatitis B vaccination in adults and children: temporary recommendations
Health Professionals are advised that this temporary advice is not absolute and requires some clinical judgement and a detailed individual risk assessment.
Advice is subject to change and will be updated as further information becomes available.
In addition, health professionals should note that the hepatitis B chapter of Immunisation against infectious disease (the Green Book) has been updated in light of the introduction of hexavalent combination vaccine (diphtheria/tetanus/acellular pertussis/ inactivated polio vaccine/Haemophilus influenzae type b/hepatitis B) into the routine infant immunisation programme from autumn 2017.